Compare AMRX & GFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMRX | GFF |
|---|---|---|
| Founded | 2002 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.2B |
| IPO Year | 2018 | 1994 |
| Metric | AMRX | GFF |
|---|---|---|
| Price | $12.94 | $91.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $15.60 | ★ $105.00 |
| AVG Volume (30 Days) | ★ 1.4M | 356.9K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.99% |
| EPS Growth | ★ 157.89 | N/A |
| EPS | 0.22 | ★ 1.41 |
| Revenue | N/A | ★ $2,519,926,000.00 |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | $7.13 | N/A |
| P/E Ratio | ★ $58.16 | $63.09 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.02 | $65.01 |
| 52 Week High | $15.42 | $97.58 |
| Indicator | AMRX | GFF |
|---|---|---|
| Relative Strength Index (RSI) | 50.83 | 65.28 |
| Support Level | $12.50 | $73.09 |
| Resistance Level | $13.54 | $97.58 |
| Average True Range (ATR) | 0.48 | 2.96 |
| MACD | -0.01 | 0.56 |
| Stochastic Oscillator | 33.95 | 78.27 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products: is a provider of branded consumer and professional tools; residential, industrial and commercial fans; home storage and organization products; and Home and Building Products conducts its operations through Clopay Corporation (Clopay). Clopay is the manufacturer and marketer of garage doors and rolling steel doors in North America. The company generates a majority of its revenue from the Home and Building Products segment. Operates in USA, Europe, Canada, Australia, and Others.